Third Security’s Armata Pharmaceuticals ARMP Stock Holding History

Third Security’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,338	Closed	-$2.41M	–	17
2016 Q3	$2.41M	Buy	11,338 +3,061	+37%	+$706K	0.11%	15
2016 Q2	$1.8M	Hold	8,277	–	–	0.09%	18
2016 Q1	$4.57M	Hold	8,277	–	–	0.18%	14
2015 Q4	$4.61M	Hold	8,277	–	–	0.18%	13
2015 Q3	$4.58M	Buy	+8,277	New	+$7.57M	0.18%	13

Other funds holding ARMP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWM

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Third Security's ARMP Position: Q4 2016 in Review

Third Security sold out of Armata Pharmaceuticals (ARMP) in Q4 2016, closing a stake of 11,338 shares — an estimated $2.41M sold.

Third Security first reported a position in ARMP in Q3 2015 and held it in 5 quarters. The position peaked at $4.61M in Q4 2015. 15 funds tracked by Wall St. Rank hold ARMP as of Q4 2016.

Third Security reported no remaining Armata Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Third Security sold 11,338 Armata Pharmaceuticals shares in Q4 2016, an estimated $2.41M.
Third Security first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Third Security's Armata Pharmaceuticals position peaked at $4.61M in Q4 2015.
15 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2016.

Based on Third Security's 13F filing for Q4 2016, filed 3 Feb 2017.